• Bestatin as a Chemical Probe of Jasmonate Signaling

  2026-09-20

  The reference study established bestatin as a chemical-genetic probe for jasmonic acid signaling in Arabidopsis and tomato, rather than merely an aminopeptidase inhibitor. By combining gene-expression analysis, pathway mutants, developmental phenotyping, and resistant-mutant screening, the authors identified distinct genetic classes that help separate jasmonate perception, response, and bestatin-specific effects.

• Tetracycline C6589 for Reliable Cell Assays

  2026-09-19

  Learn how Tetracycline (SKU C6589) can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing antibiotic selection effects with biological endpoints. This scenario-based guide covers mechanism, assay controls, DMSO preparation, interpretation, and evidence-based product selection.

• PTX3–TLR4/NF-κB–FGF21 Axis in Glucocorticoid ONFH

  2026-09-18

  The reference study identifies PTX3 as a protective regulator of glucocorticoid-induced osteonecrosis of the femoral head and places it upstream of a TLR4/NF-κB/FGF21 signaling axis. Its combination of patient samples, cellular models, knockout mice, recombinant protein rescue, and pathway blockade provides a mechanistic framework for studying impaired osteogenesis and apoptosis in ONFH.

• Mifepristone (RU486) Experimental Workflows

  2026-09-18

  Mifepristone (RU486) provides a practical pharmacological switch for testing progesterone receptor-dependent biology in cancer and reproductive models. This guide combines dose planning, receptor-context controls, quantitative readouts, and troubleshooting strategies for more interpretable experiments.

• Methyl-β-cyclodextrin Protocol and QC Guide

  2026-09-17

  Methyl-β-cyclodextrin (SKU C6939) is a 98.00% reagent for controlled membrane cholesterol extraction and studies of lipid organization, membrane fluidity, and cholesterol-dependent signaling. It is intended for scientific research only; concentration, exposure time, vehicle, and cell-model compatibility must be established empirically, and prepared solutions should not be stored long term.

• Human Sensory Neurons Model HSV-1 Latency

  2026-09-17

  Oh et al. developed a scalable human iPSC-derived sensory neuron system that reproduces major molecular and functional features of HSV-1 latency and supports chemically induced reactivation. The model provides a human-relevant platform for studying neuron-intrinsic latency mechanisms while clarifying the limitations of extrapolating from animal systems.

• Liproxstatin-1 HCl: Assay Logic

  2026-09-16

  Liproxstatin-1 HCl is examined here as a causal assay tool for separating ferroptosis from broader oxidative or apoptotic injury. The article connects its rescue phenotype with the mitochondrial calcium–GPX4 axis and explains how to interpret cellular and organ-injury results without overstating translational maturity.

• Dacarbazine in Translational Oncology

  2026-09-16

  A mechanistic and strategic framework for using Dacarbazine as a translational benchmark across DNA damage, experimental validation, competitive benchmarking, supportive care, and clinical research.

• MK-1775: Wee1 Kinase Inhibitor Workflows

  2026-09-15

  Build more informative MK-1775 experiments by separating growth arrest from cell killing, then pair Wee1 inhibition with DNA-damaging treatment in genetically defined models. This guide combines checkpoint pharmacology, time-resolved assay design, and troubleshooting for reproducible cancer research workflows.

• Targeted mRNA Nanoparticles Repair the Poststroke BBB

  2026-09-15

  Gao and colleagues developed M2 microglia-targeting lipid nanoparticles that deliver interleukin-10 mRNA to ischemic brain lesions and reinforce an anti-inflammatory feedback loop. In mouse stroke models, the approach reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and alleviated neurological deficits, with evidence suggesting a therapeutic window extending to 72 hours after stroke.

• G007-LK: Tankyrase 1/2 Inhibitor Workflows

  2026-09-14

  G007-LK enables controlled interrogation of tankyrase-dependent Wnt/β-catenin signaling, β-catenin turnover, and cancer-cell growth. Its strongest use cases span APC-mutant colorectal models, reporter assays, degradasome biology, and a carefully bounded extension into Hippo/YAP research.

• Ferroptosis Research Beyond a Rescue Compound

  2026-09-14

  Liproxstatin-1 HCl is more than a ferroptosis rescue reagent: it can serve as a mechanistic control, pathway-positioning tool, and translational bridge between lipid peroxidation biology and acute organ injury research.

• CIH, Gut Microbiota, and Mitochondrial Apoptosis

  2026-09-13

  This study integrates gut microbiome profiling, metabolomics, and mitochondrial apoptosis measurements to examine how chronic intermittent hypoxia damages the lung. Its pharmacological comparison of Mdivi-1 and CCCP links altered fatty acid metabolism and dysbiosis with mitochondrial injury, while also defining important limits on causal interpretation.

• Selonsertib (GS-4997) for Stress-Pathway Research

  2026-09-12

  Selonsertib (GS-4997) gives researchers a selective way to test whether ASK1 stress signaling contributes to autophagy failure, steatosis, inflammation, and fibrosis. This workflow pairs pathway inhibition with flux, lipid, and insulin-signaling readouts instead of treating ASK1 as a presumed upstream driver.

• Z-YVAD-FMK for Reliable Caspase-1 Assays

  2026-09-11

  Learn how Z-YVAD-FMK (SKU A8955) can strengthen mechanistic interpretation in apoptosis assays, pyroptosis research, and inflammasome activation studies. This practical guide covers model selection, controls, formulation, data interpretation, and supplier reliability.

8447 records 1/564 page Next 12345 下5页 Last page